News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Anish Bhatnagar
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 160,602 shares
@ $0
Granted 481,806 options to buy
@ $5.25, valued at
$2.5M
|
|
| 05/10/2023 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 2,143 warrants
@ $1.75, valued at
$3.8k
Granted 3,500 warrants
@ $2.5, valued at
$8.8k
|
|
| 01/27/2023 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 115,000 options to buy
@ $2.41, valued at
$277.2k
|
|
| 10/14/2022 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC |
| 07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 60,000 shares
@ $0
Bought 60,000 warrants
@ $0.3, valued at
$18k
|
|
| 02/01/2022 |
4
| Anish Bhatnagar (See Remarks) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 610,000 options to buy
@ $0.34, valued at
$207.4k
|
|
| 01/25/2022 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Sold 39,033 shares
@ $0.373, valued at
$14.6k
|
|
| 01/26/2021 |
4/A
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 36,318 shares
@ $2.11, valued at
$76.6k
|
|
| 01/26/2021 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 36,318 shares
@ $2.11, valued at
$76.6k
|
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Anish Bhatnagar (See Remarks) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 350,000 options to buy
@ $3.41, valued at
$1.2M
|
|
| 01/24/2020 |
4
| Anish Bhatnagar (CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 381,000 shares
@ $3.35, valued at
$1.3M
|
|
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2018 |
4
| Anish Bhatnagar (President and CEO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 400,000 options to buy
@ $1.6, valued at
$640k
Granted 100,625 restricted stock units
@ $0 |
|
| 04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/22/2016 |
4
| Anish Bhatnagar (See Remarks) has filed a Form 4 on Capnia, Inc.|
Txns:
| Bought 10,000 shares
@ $0.96, valued at
$9.6k
|
|
| 06/10/2016 |
4
| Anish Bhatnagar (See Remarks) has filed a Form 4 on Capnia, Inc.|
Txns:
| Granted 301,175 options to buy
@ $1.2, valued at
$361.4k
|
|
| 05/16/2016 |
4
| Anish Bhatnagar (President and CEO) has filed a Form 4 on Capnia, Inc.|
Txns:
| Bought 5,000 shares
@ $1.149, valued at
$5.7k
|
|
| 04/11/2016 |
4
| Anish Bhatnagar (President and CEO) has filed a Form 4 on Capnia, Inc.|
Txns:
| Exercised 58,419 options to buy
@ $1.2, valued at
$70.1k
|
|
|
|